Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Filings indexed 280 across all filing types
Latest filing 2024-09-24 Regulatory Filings
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited regarding the closure of the trading window for insiders around the announcement of quarterly financial results. It informs about the trading restrictions for promoters, directors, and key personnel in compliance with insider trading regulations. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement related to trading compliance rather than a financial report or earnings release. Given the short length (1468 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-09-24 English
Shareholders meeting
Regulatory Filings
2024-09-03 English
Book Closure
AGM Information Classification · 95% confidence The document is an intimation to the stock exchange regarding the Annual General Meeting (AGM) of Arvee Laboratories (India) Limited. It specifies the date and venue of the AGM, the book closure dates, and related procedural details as per SEBI regulations. The document does not contain any financial statements, detailed financial performance, or management discussion. It is a notification about the AGM event rather than the AGM materials or the annual report itself. The document length is short (1956 characters), and it serves as an announcement of the AGM date and related administrative details, fitting the category of AGM Information (AGM-R).
2024-08-14 English
Outcome of Board Meeting
Regulatory Filings
2024-08-13 English
Outcome of Board Meeting
Regulatory Filings
2024-08-13 English
Financial Result Updates
Regulatory Filings
2024-08-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.